TIFFANY FRYER: Open Payments
NPI 1992488183 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 20 payments from 3 companies in 2025. Trend: 2023 $41 · 2024 $151 · 2025 $349
Food & beverage: $238Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $149 |
| Otsuka America Pharmaceutical, Inc. | 13 | $135 |
| Alkermes, Inc. | 4 | $65 |
Products named: REXULTI, ARISTADA, UZEDY, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across AL — which companies pay providers there.
